The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. - Mullish, BH; Quraishi, MN; Segal, JP; McCune, VL; Baxter, M; Marsden, GL; Moore, DJ; Colville, A; Bhala, N; Iqbal, TH; Settle, C; Kontkowski, G; et al. (Gut, 2018)